Biomatter
PrivateLast Round
Seed
Aug 5, 2024
Total Funding Raised
$7.74M
Momentum Score
25 /100
Company Overview
Biomatter is a synthetic biology company that has developed an AI-powered platform to design and create new proteins and enzymes for applications in medicine, agriculture, and chemical biomanufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomatter Comps
Public and private peers based on sector, stage, and business model.
Biomatter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 5, 2024 | ||||
| Seed | Jan 11, 2021 |
Key People
Founding team and executive leadership
Biomatter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metaplanet Holdings | Seed |
| Practica Capital | Seed |
| Inventure | Seed |
| 70V | Seed |
| UVC Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors grew 294% MoM, from 453 to 1.8K.
- May 2, 2025
Monthly visitors grew 3900% MoM, reaching 2.4K.
Biomatter Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biomatter's valuation, stock price, and market status.
